Answer
Ketoconazole, a strong CYP3A4 inhibitor, reduced docetaxel clearance by 49% in a seven-patient study; if concomitant use cannot be avoided, close clinical surveillance is warranted and docetaxel dose adjustment may be appropriate because adverse reactions may increase.
Sources for this answer
- Docetaxel 20 mg/ml concentrate for solution for infusionSeacross Pharmaceuticals Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 7Document updated
Sources checked